吡柔比星（Ｐｉｒａｒｕｂｉｃｉｎ，ＴＨＰ）为新一代的蒽环类抗肿瘤药物，我们从１９９５年１０月～１９９７年１０月，应用以吡柔比星为主的联合化疗方案治疗各种儿童恶性肿瘤３８例，并与同期应用表阿霉素为主的联合化疗治疗３０例患儿作疗效及副作用比较，现报告如下... Pirarubicin (THP) is a new generation of anthracycline antitumor drugs. From October 1995 to October 1997, we used a combination of pirarubicin-based chemotherapy in the treatment of various childhood malignancies 38 cases, and with the same period of epirubicin-based chemotherapy combined with 30 cases of children treated for efficacy and side effects, are reported as follows ...